The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Salbutamol Oral Liquid Market Research Report 2024

Global Salbutamol Oral Liquid Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1737004

No of Pages : 97

Synopsis
Salbutamol Oral Liquid is an oral liquid containing salbutamol hydrochloride as an active ingredient, which is commonly used in the treatment of asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases.

Global Salbutamol Oral Liquid market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Salbutamol Oral Liquid market research.

Key manufacturers engaged in the Salbutamol Oral Liquid industry include Teva Pharmaceuticals, Wockhardt, Sandoz, Perrigo Company, GlaxoSmithKline, Mylan Pharmaceuticals, Lupin Pharmaceuticals, Apotex and Novartis Pharmaceuticals Corporation, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Salbutamol Oral Liquid were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Salbutamol Oral Liquid market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Salbutamol Oral Liquid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Teva Pharmaceuticals
  • Wockhardt
  • Sandoz
  • Perrigo Company
  • GlaxoSmithKline
  • Mylan Pharmaceuticals
  • Lupin Pharmaceuticals
  • Apotex
  • Novartis Pharmaceuticals Corporation
  • Aurobindo Pharma

Segment by Type

  • Ipratropium Bromide
  • Salbutamol Sulfate

Segment by Application

  • Hospital
  • Clinic
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Salbutamol Oral Liquid report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

List of Tables
Table 1. Global Salbutamol Oral Liquid Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Salbutamol Oral Liquid Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Salbutamol Oral Liquid Market Competitive Situation by Manufacturers in 2022
Table 4. Global Salbutamol Oral Liquid Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Salbutamol Oral Liquid Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Salbutamol Oral Liquid Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Salbutamol Oral Liquid Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Salbutamol Oral Liquid Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Salbutamol Oral Liquid, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Salbutamol Oral Liquid, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Salbutamol Oral Liquid, Product Type & Application
Table 12. Global Key Manufacturers of Salbutamol Oral Liquid, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Salbutamol Oral Liquid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Salbutamol Oral Liquid as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Salbutamol Oral Liquid Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Salbutamol Oral Liquid Sales by Region (2018-2023) & (K Units)
Table 18. Global Salbutamol Oral Liquid Sales Market Share by Region (2018-2023)
Table 19. Global Salbutamol Oral Liquid Sales by Region (2024-2029) & (K Units)
Table 20. Global Salbutamol Oral Liquid Sales Market Share by Region (2024-2029)
Table 21. Global Salbutamol Oral Liquid Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Salbutamol Oral Liquid Revenue Market Share by Region (2018-2023)
Table 23. Global Salbutamol Oral Liquid Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Salbutamol Oral Liquid Revenue Market Share by Region (2024-2029)
Table 25. North America Salbutamol Oral Liquid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Salbutamol Oral Liquid Sales by Country (2018-2023) & (K Units)
Table 27. North America Salbutamol Oral Liquid Sales by Country (2024-2029) & (K Units)
Table 28. North America Salbutamol Oral Liquid Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Salbutamol Oral Liquid Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Salbutamol Oral Liquid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Salbutamol Oral Liquid Sales by Country (2018-2023) & (K Units)
Table 32. Europe Salbutamol Oral Liquid Sales by Country (2024-2029) & (K Units)
Table 33. Europe Salbutamol Oral Liquid Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Salbutamol Oral Liquid Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Salbutamol Oral Liquid Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Salbutamol Oral Liquid Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Salbutamol Oral Liquid Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Salbutamol Oral Liquid Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Salbutamol Oral Liquid Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Salbutamol Oral Liquid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Salbutamol Oral Liquid Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Salbutamol Oral Liquid Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Salbutamol Oral Liquid Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Salbutamol Oral Liquid Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Salbutamol Oral Liquid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Salbutamol Oral Liquid Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Salbutamol Oral Liquid Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Salbutamol Oral Liquid Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Salbutamol Oral Liquid Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Salbutamol Oral Liquid Sales (K Units) by Type (2018-2023)
Table 51. Global Salbutamol Oral Liquid Sales (K Units) by Type (2024-2029)
Table 52. Global Salbutamol Oral Liquid Sales Market Share by Type (2018-2023)
Table 53. Global Salbutamol Oral Liquid Sales Market Share by Type (2024-2029)
Table 54. Global Salbutamol Oral Liquid Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Salbutamol Oral Liquid Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Salbutamol Oral Liquid Revenue Market Share by Type (2018-2023)
Table 57. Global Salbutamol Oral Liquid Revenue Market Share by Type (2024-2029)
Table 58. Global Salbutamol Oral Liquid Price (US$/Unit) by Type (2018-2023)
Table 59. Global Salbutamol Oral Liquid Price (US$/Unit) by Type (2024-2029)
Table 60. Global Salbutamol Oral Liquid Sales (K Units) by Application (2018-2023)
Table 61. Global Salbutamol Oral Liquid Sales (K Units) by Application (2024-2029)
Table 62. Global Salbutamol Oral Liquid Sales Market Share by Application (2018-2023)
Table 63. Global Salbutamol Oral Liquid Sales Market Share by Application (2024-2029)
Table 64. Global Salbutamol Oral Liquid Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Salbutamol Oral Liquid Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Salbutamol Oral Liquid Revenue Market Share by Application (2018-2023)
Table 67. Global Salbutamol Oral Liquid Revenue Market Share by Application (2024-2029)
Table 68. Global Salbutamol Oral Liquid Price (US$/Unit) by Application (2018-2023)
Table 69. Global Salbutamol Oral Liquid Price (US$/Unit) by Application (2024-2029)
Table 70. Teva Pharmaceuticals Corporation Information
Table 71. Teva Pharmaceuticals Description and Business Overview
Table 72. Teva Pharmaceuticals Salbutamol Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Teva Pharmaceuticals Salbutamol Oral Liquid Product
Table 74. Teva Pharmaceuticals Recent Developments/Updates
Table 75. Wockhardt Corporation Information
Table 76. Wockhardt Description and Business Overview
Table 77. Wockhardt Salbutamol Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Wockhardt Salbutamol Oral Liquid Product
Table 79. Wockhardt Recent Developments/Updates
Table 80. Sandoz Corporation Information
Table 81. Sandoz Description and Business Overview
Table 82. Sandoz Salbutamol Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Sandoz Salbutamol Oral Liquid Product
Table 84. Sandoz Recent Developments/Updates
Table 85. Perrigo Company Corporation Information
Table 86. Perrigo Company Description and Business Overview
Table 87. Perrigo Company Salbutamol Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Perrigo Company Salbutamol Oral Liquid Product
Table 89. Perrigo Company Recent Developments/Updates
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Salbutamol Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. GlaxoSmithKline Salbutamol Oral Liquid Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Mylan Pharmaceuticals Corporation Information
Table 96. Mylan Pharmaceuticals Description and Business Overview
Table 97. Mylan Pharmaceuticals Salbutamol Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Mylan Pharmaceuticals Salbutamol Oral Liquid Product
Table 99. Mylan Pharmaceuticals Recent Developments/Updates
Table 100. Lupin Pharmaceuticals Corporation Information
Table 101. Lupin Pharmaceuticals Description and Business Overview
Table 102. Lupin Pharmaceuticals Salbutamol Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Lupin Pharmaceuticals Salbutamol Oral Liquid Product
Table 104. Lupin Pharmaceuticals Recent Developments/Updates
Table 105. Apotex Corporation Information
Table 106. Apotex Description and Business Overview
Table 107. Apotex Salbutamol Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Apotex Salbutamol Oral Liquid Product
Table 109. Apotex Recent Developments/Updates
Table 110. Novartis Pharmaceuticals Corporation Corporation Information
Table 111. Novartis Pharmaceuticals Corporation Description and Business Overview
Table 112. Novartis Pharmaceuticals Corporation Salbutamol Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Novartis Pharmaceuticals Corporation Salbutamol Oral Liquid Product
Table 114. Novartis Pharmaceuticals Corporation Recent Developments/Updates
Table 115. Aurobindo Pharma Corporation Information
Table 116. Aurobindo Pharma Description and Business Overview
Table 117. Aurobindo Pharma Salbutamol Oral Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Aurobindo Pharma Salbutamol Oral Liquid Product
Table 119. Aurobindo Pharma Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Salbutamol Oral Liquid Distributors List
Table 123. Salbutamol Oral Liquid Customers List
Table 124. Salbutamol Oral Liquid Market Trends
Table 125. Salbutamol Oral Liquid Market Drivers
Table 126. Salbutamol Oral Liquid Market Challenges
Table 127. Salbutamol Oral Liquid Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Salbutamol Oral Liquid
Figure 2. Global Salbutamol Oral Liquid Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Salbutamol Oral Liquid Market Share by Type in 2022 & 2029
Figure 4. Ipratropium Bromide Product Picture
Figure 5. Salbutamol Sulfate Product Picture
Figure 6. Global Salbutamol Oral Liquid Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Salbutamol Oral Liquid Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Salbutamol Oral Liquid Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Salbutamol Oral Liquid Market Size (2018-2029) & (US$ Million)
Figure 13. Global Salbutamol Oral Liquid Sales (2018-2029) & (K Units)
Figure 14. Global Salbutamol Oral Liquid Average Price (US$/Unit) & (2018-2029)
Figure 15. Salbutamol Oral Liquid Report Years Considered
Figure 16. Salbutamol Oral Liquid Sales Share by Manufacturers in 2022
Figure 17. Global Salbutamol Oral Liquid Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Salbutamol Oral Liquid Players: Market Share by Revenue in 2022
Figure 19. Salbutamol Oral Liquid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Salbutamol Oral Liquid Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Salbutamol Oral Liquid Sales Market Share by Country (2018-2029)
Figure 22. North America Salbutamol Oral Liquid Revenue Market Share by Country (2018-2029)
Figure 23. United States Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Salbutamol Oral Liquid Sales Market Share by Country (2018-2029)
Figure 26. Europe Salbutamol Oral Liquid Revenue Market Share by Country (2018-2029)
Figure 27. Germany Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Salbutamol Oral Liquid Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Salbutamol Oral Liquid Revenue Market Share by Region (2018-2029)
Figure 34. China Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Salbutamol Oral Liquid Sales Market Share by Country (2018-2029)
Figure 42. Latin America Salbutamol Oral Liquid Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Salbutamol Oral Liquid Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Salbutamol Oral Liquid Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Salbutamol Oral Liquid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Salbutamol Oral Liquid by Type (2018-2029)
Figure 53. Global Revenue Market Share of Salbutamol Oral Liquid by Type (2018-2029)
Figure 54. Global Salbutamol Oral Liquid Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Salbutamol Oral Liquid by Application (2018-2029)
Figure 56. Global Revenue Market Share of Salbutamol Oral Liquid by Application (2018-2029)
Figure 57. Global Salbutamol Oral Liquid Price (US$/Unit) by Application (2018-2029)
Figure 58. Salbutamol Oral Liquid Value Chain
Figure 59. Salbutamol Oral Liquid Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’